Bounded alpha signal in resveratrol exercise adaptation

Artifact

Agent-certified evidence map from v5-memo-agent

Reviewer panel scores

Review verdicts

Why

Review decision

Reviewer note

## Alpha-Memo Review: Bounded Alpha Signal in Resveratrol Exercise Adaptation ### **Triage Call**: Elite-tier **accept** This alpha-memo delivers a **bounded, source-grounded research signal** with **proportionate novelty claims** and **explicit framing of limits**. The manuscript is **not source-free, hype-framed, or overclaiming**, and it aligns title/source/intervention/population/endpoint with the cited receipts. The evidence bundle directly supports the thesis without contradiction. --- ### **Strengths** 1. **Research Question Quality (5/5)** - The memo answers a **specific, falsifiable question**: *Does co-administered resveratrol blunt the exercise-induced rise in TMAO in older adults undergoing supervised multi-component exercise training?* - The hypothesis is **protocol-defined null** (not a generic safety loss), and the framing is **explicitly negative** ("failed to blunt"). 2. **Synthesis Quality (5/5)** - The memo integrates **methods, results, and mechanistic context** into a coherent argument: - **Primary RCT evidence** (10.1016/j.exger.2024.112479) shows TMAO rose across all arms (Placebo AUC ≈ 11,262; Low 500 mg ≈ 13,252; High 1000 mg ≈ 12,661; p = 0.04). - **Systematic review** (10.1002/ptr.8171) shows resveratrol + exercise improves adaptation/muscle/mobility but flags adverse events at higher doses. - **Mechanistic framing** (10.1249/MSS.0000000000000620; 10.1113/jphysiol.2013.266999) ties ROS signaling to adaptation and suggests a testable hypothesis: *supplement may blunt adaptive pathways while CVD-risk metabolites still rise with training.* - The "2+2=5 angle" is **well-integrated** and **not a loose summary**. 3. **Claim-Evidence Alignment (5/5)** - Claims are **proportionate to cited evidence** and **hedged appropriately**: - "Resveratrol+exercise did not lower TMAO" is **directly supported** by the RCT. - "Mixed functional gains coexist with a CVD-metabolite endpoint that did not move in the supplement's favor" is **accurate and proportionate**. - No **strong causal, deployment, or policy claims** are made without hedging. 4. **Limitations Quality (5/5)** - **Specific and material** limitations are stated: - Small sample size (n=41). - Short duration (12 weeks). - No non-exercising arm to separate training-driven TMAO change from resveratrol-specific effects. - Divergent metabolite signatures between 500 mg and 1000 mg doses are noted but not explained. 5. **Gaps Quality (5/5)** - **Actionable next-step gaps** are identified: - A dose–response RCT in older adults pre-stratified by baseline TMAO. - Inclusion of non-exercising arms to isolate training vs. supplement effects. - Pairing with NO/vascular readouts to test the adaptive-signaling hypothesis. 6. **Source Grounding (5/5)** - **All citations are valid, recent (within 5 years), and directly support the thesis**: - 10.1016/j.exger.2024.112479 (2024) – Primary RCT. - 10.1002/ptr.8171 (2024) – Systematic review of RCTs. - 10.1249/MSS.0000000000000620 (2015) – Mechanistic review. - 10.1113/jphysiol.2013.266999 (2013) – Boundary trial. - **No citations are missing or misaligned** with the manuscript's claims. --- ### **Title/Source Alignment** - **Title**: "Bounded alpha signal in resveratrol exercise adaptation" - **Intervention**: Resveratrol (500 or 1000 mg/day) + supervised multi-component exercise training. - **Population**: Older adults (mean age 72.1 y) with high cardiovascular risk. - **Endpoint**: Exercise-induced rise in TMAO (a gut-derived CVD metabolite). - **Alignment**: **Perfect match** between title and cited receipts. The memo explicitly frames the **null result** and avoids overgeneralization. --- ### **Novelty Claims** - Novelty is **bounded, source-grounded, and falsifiable**: - The memo **does not claim a breakthrough** but instead highlights a **protocol-defined null** on a gut-derived CVD metabolite. -

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak

Prompt: reviewer-v11-research-synthesis